Myelodysplastic/myeloproliferative diseases is a medical condition with active clinical research programs worldwide.

17 total trials for this combination

Showing top 10 of 17 trials

Trials

NCT ID	Title	Status	Phase
NCT00410657	Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant	COMPLETED	PHASE2
NCT00003913	Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease	COMPLETED	PHASE2
NCT00719849	Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematological Cancer or Other Disease	TERMINATED	PHASE2
NCT00066248	Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment	COMPLETED	PHASE2
NCT00062140	Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer	COMPLETED	PHASE1
NCT00075816	Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)	COMPLETED	PHASE3
NCT00089037	Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation	COMPLETED	PHASE1/PHASE2
NCT00096096	Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation	COMPLETED	PHASE2
NCT00082654	Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients	COMPLETED	NA
NCT00055653	Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders	COMPLETED	PHASE2

Related Pages

All Myelodysplastic/myeloproliferative diseases trials All trials in Seattle, United States